Iron Status in Small Cell Lung Cancer Patients
Author Information
Author(s): N. Milman, H. Sengeløv, P. Dombernowsky
Primary Institution: Gentofte Hospital
Hypothesis
The study aims to evaluate changes in iron status markers in patients with small cell carcinoma of the lung and their relation to survival.
Conclusion
Higher serum ferritin levels at diagnosis are associated with shorter survival in patients with small cell lung cancer.
Supporting Evidence
- Patients with serum ferritin <400 µg/L had longer survival than those with higher levels.
- Chemotherapy caused a significant drop in hemoglobin levels.
- Serum iron levels increased significantly after chemotherapy.
Takeaway
This study looked at how iron levels change in lung cancer patients and found that those with lower iron levels lived longer.
Methodology
A longitudinal study measuring iron status markers in patients with small cell lung cancer before and during chemotherapy.
Limitations
The study had a small sample size and excluded patients with very short survival.
Participant Demographics
31 patients (24 males, 7 females) with a median age of 64 years.
Statistical Information
P-Value
p<0.0002
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website